{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:44:01Z","timestamp":1768322641090,"version":"3.49.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/bpo.0b013e31828121b8","type":"journal-article","created":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T12:43:13Z","timestamp":1363092193000},"page":"269-275","source":"Crossref","is-referenced-by-count":56,"title":["Approaches to Treating NF1 Tibial Pseudarthrosis"],"prefix":"10.1097","volume":"33","author":[{"given":"David A.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlea","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin H.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Greggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Hunter-Schaedle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Kendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Kolanczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergal","family":"Monsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Oetgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Stephens","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K.","family":"Schorry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Viskochil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florent","family":"Elefteriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"R2-10-20210227","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1399-0004.2005.00410.x","article-title":"Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1).","volume":"67","author":"Alwan","year":"2005","journal-title":"Clin Genet"},{"key":"R4-10-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048","article-title":"Bone mineral density in children and adolescents with neurofibromatosis type 1.","volume":"150","author":"Stevenson","year":"2007","journal-title":"J Pediatr"},{"key":"R5-10-20210227","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.bpb.0000271310.87997.ae","article-title":"Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort.","volume":"27","author":"Dulai","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"R6-10-20210227","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00198-004-1801-4","article-title":"Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body.","volume":"16","author":"Kuorilehto","year":"2005","journal-title":"Osteoporos Int"},{"key":"R7-10-20210227","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","article-title":"Decreased bone mineral density in patients with neurofibromatosis 1.","volume":"16","author":"Lammert","year":"2005","journal-title":"Osteoporos Int"},{"key":"R8-10-20210227","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1651-2227.2007.00401.x","article-title":"Bone mineral density in children with neurofibromatosis 1.","volume":"96","author":"Yilmaz","year":"2007","journal-title":"Acta Paediatr"},{"key":"R9-10-20210227","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","article-title":"Generalized metabolic bone disease in neurofibromatosis type 1.","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R10-10-20210227","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00198-009-0933-y","article-title":"High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1.","volume":"21","author":"Seitz","year":"2010","journal-title":"Osteoporos Int"},{"key":"R11-10-20210227","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/jmg.2008.061895","article-title":"Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1).","volume":"46","author":"Tucker","year":"2009","journal-title":"J Med Genet"},{"key":"R12-10-20210227","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ajmg.a.33965","article-title":"Multiple increased osteoclast functions in individuals with neurofibromatosis type 1.","volume":"155A","author":"Stevenson","year":"2011","journal-title":"Am J Med Genet A"},{"key":"R13-10-20210227","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bone.2010.06.001","article-title":"Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation.","volume":"47","author":"Heerva","year":"2010","journal-title":"Bone"},{"key":"R14-10-20210227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/jpem.2011.092","article-title":"Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1.","volume":"24","author":"Stevenson","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R15-10-20210227","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jmg.2006.041095","article-title":"Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.","volume":"43","author":"Lammert","year":"2006","journal-title":"J Med Genet"},{"key":"R16-10-20210227","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","article-title":"Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.","volume":"70","author":"Friedman","year":"1997","journal-title":"Am J Med Genet"},{"key":"R17-10-20210227","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00003086-198206000-00004","article-title":"Congenital pseudarthrosis of the tibia: a long-term follow-up study.","volume":"166","author":"Murray","year":"1982","journal-title":"Clin Orthop Relat Res"},{"key":"R18-10-20210227","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ajmg.a.33045","article-title":"Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options.","volume":"149A","author":"Elefteriou","year":"2009","journal-title":"Am J Med Genet"},{"key":"R19-10-20210227","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/504441","article-title":"Double inactivation of NF1 in tibial pseudarthrosis.","volume":"79","author":"Stevenson","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R20-10-20210227","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00776-007-1142-1","article-title":"Congenital pseudarthrosis of the tibia: analysis of the histology and the NF1 gene.","volume":"12","author":"Sakamoto","year":"2007","journal-title":"J Orthop Sci"},{"key":"R21-10-20210227","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01202412-200001000-00002","article-title":"Pathology of bone lesions associated with congenital pseudarthrosis of the leg.","volume":"9","author":"Ippolito","year":"2000","journal-title":"J Pediatr Orthop B"},{"key":"R22-10-20210227","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2106\/JBJS.H.00014","article-title":"Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1.","volume":"90","author":"Cho","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"R23-10-20210227","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bone.2008.10.050","article-title":"Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.","volume":"44","author":"Leskela","year":"2009","journal-title":"Bone"},{"key":"R24-10-20210227","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1359\/JBMR.040130","article-title":"NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.","volume":"19","author":"Kuorilehto","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R25-10-20210227","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1093\/hmg\/ddr310","article-title":"Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type 1.","volume":"20","author":"Wang","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R26-10-20210227","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bone.2005.01.022","article-title":"Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.","volume":"36","author":"Yu","year":"2005","journal-title":"Bone"},{"key":"R27-10-20210227","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/hmg\/ddl208","article-title":"Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stemprogenitor cells.","volume":"15","author":"Wu","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R28-10-20210227","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI29092","article-title":"Hyperactivation of p21 and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.","volume":"116","author":"Yang","year":"2006","journal-title":"J Clin Invest"},{"key":"R29-10-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","article-title":"ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.","volume":"4","author":"Elefteriou","year":"2006","journal-title":"Cell Metab"},{"key":"R30-10-20210227","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann cell origin and role of tumor environment.","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"},{"key":"R31-10-20210227","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1 and c-kit-dependent bone marrow.","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"R32-10-20210227","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.bone.2011.03.760","article-title":"Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.","volume":"48","author":"Zhang","year":"2011","journal-title":"Bone"},{"key":"R33-10-20210227","doi-asserted-by":"crossref","first-page":"e24917","DOI":"10.1371\/journal.pone.0024917","article-title":"The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"R34-10-20210227","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth.","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R35-10-20210227","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1741-7015-6-21","article-title":"Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.","volume":"6","author":"Kolancyzk","year":"2008","journal-title":"BMC Med"},{"key":"R36-10-20210227","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jor.20481","article-title":"Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.","volume":"26","author":"Schindeler","year":"2008","journal-title":"J Orthop Res"},{"key":"R37-10-20210227","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jbmr.42","article-title":"Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.","volume":"25","author":"Wang","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R38-10-20210227","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jbmr.528","article-title":"A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuringproliferative fibrous tissue and osteoclast-like cells.","volume":"27","author":"El-Hoss","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R39-10-20210227","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1302\/0301-620X.93B8.25940","article-title":"Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate.","volume":"93","author":"Schindeler","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"R40-10-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01241398-199403000-00005","article-title":"Congenital pseudarthrosis of the tibia: treatment by transfer of the ipsilateral fibula with vascular pedicle.","volume":"14","author":"Coleman","year":"1994","journal-title":"J Pediatric Orthop"},{"key":"R41-10-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01202412-200001000-00001","article-title":"Editorial. Congenital pseudarthrosis of the tibia: part 1.","volume":"9","author":"Weintroub","year":"2000","journal-title":"J Pediatr Orthop"},{"key":"R42-10-20210227","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1302\/0301-620X.63B3.6790551","article-title":"Congenital pseudarthrosis of the tibia.","volume":"63-B","author":"Morrissy","year":"1981","journal-title":"J Bone Joint Surg Br"},{"key":"R43-10-20210227","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01202412-200004000-00004","article-title":"Functional results at the end of skeletal growth in 30 patients affected by congenital pseudoarthrosis of the tibia.","volume":"9","author":"Tudisco","year":"2000","journal-title":"J Pediatr Orthop B"},{"key":"R44-10-20210227","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01241398-199911000-00008","article-title":"Congenital pseudarthrosis of the tibia: a retrospective review.","volume":"19","author":"Traub","year":"1999","journal-title":"J Pediatr Orthop B"},{"key":"R45-10-20210227","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2106\/00004623-200406000-00010","article-title":"Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study.","volume":"86-A","author":"Dobbs","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"R46-10-20210227","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2106\/00004623-200210000-00010","article-title":"Congential pseudarthrosis of the tibia: results of technical variations in the charnley-williams procedure.","volume":"84-A","author":"Johnston","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"R47-10-20210227","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2106\/JBJS.H.01667","article-title":"The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series.","volume":"92","author":"Richards","year":"2010","journal-title":"J Bone Joint Surg Am"},{"key":"R48-10-20210227","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/BPO.0b013e318202c45d","article-title":"Congenital pseudarthrosis of the tibia treated with intramedullary rodding and cortical bone grafting: a follow-up study at skeletal maturity.","volume":"31","author":"Shah","year":"2011","journal-title":"J Pediatr Orthop"},{"key":"R49-10-20210227","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1007\/s11999-008-0556-1","article-title":"Periosteal grafting for congenital pseudarthrosis of the tibia: a preliminary report.","volume":"466","author":"Thabet","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"R50-10-20210227","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11832-008-0139-4","article-title":"Association of Ilizarovs technique and intramedullary rodding in the treatment of congenital pseudarthrosis of the tibia.","volume":"2","author":"Mathieu","year":"2008","journal-title":"J Child Orthop"},{"key":"R51-10-20210227","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/micr.20649","article-title":"Vascularized free fibular bone graft in the management of congenital tibial pseudarthrosis.","volume":"29","author":"Korompilias","year":"2009","journal-title":"Microsurgery"},{"key":"R52-10-20210227","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.bjps.2009.09.016","article-title":"Vascularised fibula grafts for early tibia reconstruction in infants with congenital pseudarthrosis.","volume":"63","author":"Erni","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R53-10-20210227","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00264-010-1103-8","article-title":"Vascularised fibular graft for the treatment of congenital pseudarthrosis of the tibia: long-term complications in the donor leg.","volume":"35","author":"Iamaguchi","year":"2011","journal-title":"Int Orthop"},{"key":"R54-10-20210227","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/BPO.0b013e318202c243","article-title":"Transfer of ipsilateral fibula on vascular pedicle for treatment of congenital pseudarthrosis of the tibia.","volume":"31","author":"Tan","year":"2011","journal-title":"J Pediatr Orthop"},{"key":"R55-10-20210227","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BPO.0b013e3181d075ab","article-title":"Complications associated with the use of bone morphogenetic protein in pediatric patients.","volume":"30","author":"Oetgen","year":"2010","journal-title":"J Pediatr Orthop"},{"key":"R57-10-20210227","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11832-010-0293-3","article-title":"Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.","volume":"4","author":"Birke","year":"2010","journal-title":"J Child Orthop"},{"key":"R58-10-20210227","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins.","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"}],"container-title":["Journal of Pediatric Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BPO.0b013e31828121b8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T04:44:56Z","timestamp":1644554696000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01241398-201304000-00010"}},"subtitle":["Consensus From the Children\u2019s Tumor Foundation NF1 Bone Abnormalities Consortium"],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/bpo.0b013e31828121b8","relation":{},"ISSN":["0271-6798"],"issn-type":[{"value":"0271-6798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}